Distinguished in Prekallikrein Deficiency

Dr. Kenneth D. Nahum

Hematology Oncology | Hematology | Oncology
Regional Cancer Care Associates LLC
4632 Hwy 9, 
Howell, NJ 
Accepting New Patients
Offers Telehealth
Distinguished in Prekallikrein Deficiency
Regional Cancer Care Associates LLC
4632 Hwy 9, 
Howell, NJ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Kenneth Nahum is a Hematologist Oncology specialist and a Hematologist in Howell, New Jersey. Dr. Nahum is rated as a Distinguished provider by MediFind in the treatment of Prekallikrein Deficiency. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, Bone Marrow Aspiration, and Fasciotomy. Dr. Nahum is currently accepting new patients.

His clinical research consists of co-authoring 5 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in NJ
Hospital Affiliations
Community Medical Center
Ocean Medical Center
Centrastate Medical Center
Monmouth Medical Center-Southern Campus
Jersey Shore University Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

REGIONAL CANCER CARE ASSOCIATES LLC
4632 Hwy 9, Howell, NJ 07731

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: October 09, 2025
Intervention Type: Other, Radiation, Procedure, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3
An Observational Study Assessing the Clinical Effectiveness of VeriStrat and Validating Immunotherapy Tests in Subjects With Non-Small Cell Lung Cancer
An Observational Study Assessing the Clinical Effectiveness of VeriStrat and Validating Immunotherapy Tests in Subjects With Non-Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 19, 2025
A Phase III Randomized, Double-blind, Placebo-controlled Study of LEE011 or Placebo in Combination With Tamoxifen and Goserelin or a Non-steroidal Aromatase Inhibitor (NSAI) and Goserelin for the Treatment of Premenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
A Phase III Randomized, Double-blind, Placebo-controlled Study of LEE011 or Placebo in Combination With Tamoxifen and Goserelin or a Non-steroidal Aromatase Inhibitor (NSAI) and Goserelin for the Treatment of Premenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
Enrollment Status: Completed
Publish Date: March 12, 2024
Intervention Type: Drug
Study Drugs: LEE011, Tamoxifen, Letrozole, Anastrozole, Goserelin
Study Phase: Phase 3
Quantitative Targeted Proteomics Detected by Mass Spectrometry With Whole Genome (DNA) and Whole Transcriptome (RNA) Sequencing in Advanced Cancers
Quantitative Targeted Proteomics Detected by Mass Spectrometry With Whole Genome (DNA) and Whole Transcriptome (RNA) Sequencing in Advanced Cancers
Enrollment Status: Terminated
Publish Date: July 20, 2018
Intervention Type: Diagnostic test
View 3 Less Clinical Trials

5 Total Publications

An Interesting Case of Prostate Cancer Presenting With Colonic Metastasis.
An Interesting Case of Prostate Cancer Presenting With Colonic Metastasis.
Journal: Cureus
Published: February 03, 2023
Similar Doctors
Distinguished in Prekallikrein Deficiency
Dr. Said A. Saleh
Hematology Oncology | Hematology | Oncology
Distinguished in Prekallikrein Deficiency
Dr. Said A. Saleh
Hematology Oncology | Hematology | Oncology

Barnabas Health Medical Group PC

201 Lyons Ave, 
Newark, NJ 
 (39.5 miles away)
973-467-9282
Languages Spoken:
English, Arabic, Italian, Spanish
See accepted insurances
Accepting New Patients

Said Saleh is a Hematologist Oncology specialist and a Hematologist in Newark, New Jersey. Dr. Saleh is rated as a Distinguished provider by MediFind in the treatment of Prekallikrein Deficiency. His top areas of expertise are Iron Deficiency Anemia, Thrombocytopenia, Childhood Iron Deficiency Anemia, Anemia, and Endoscopy. Dr. Saleh is currently accepting new patients.

Advanced in Prekallikrein Deficiency
Dr. Hemalatha Vasireddy
Hematology Oncology | Hematology | Oncology
Advanced in Prekallikrein Deficiency
Dr. Hemalatha Vasireddy
Hematology Oncology | Hematology | Oncology

Regional Cancer Care Associates LLC

776 E 3rd Ave, 
Roselle, NJ 
 (36.0 miles away)
908-259-8817
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients

Hemalatha Vasireddy is a Hematologist Oncology specialist and a Hematologist in Roselle, New Jersey. Dr. Vasireddy is rated as a Distinguished provider by MediFind in the treatment of Prekallikrein Deficiency. Her top areas of expertise are Paget Disease of the Breast, Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Colorectal Cancer, and Bone Marrow Aspiration. Dr. Vasireddy is currently accepting new patients.

Advanced in Prekallikrein Deficiency
Dr. James M. Orsini
Hematology Oncology | Hematology | Oncology
Advanced in Prekallikrein Deficiency
Dr. James M. Orsini
Hematology Oncology | Hematology | Oncology

Regional Cancer Care Associates LLC

1 Bay Ave, 
Montclair, NJ 
 (46.5 miles away)
973-429-6096
Languages Spoken:
English, Italian
See accepted insurances
Accepting New Patients
Offers Telehealth

James Orsini is a Hematologist Oncology specialist and a Hematologist in Montclair, New Jersey. Dr. Orsini is rated as an Advanced provider by MediFind in the treatment of Prekallikrein Deficiency. His top areas of expertise are Colorectal Cancer, Iron Deficiency Anemia, Familial Prostate Cancer, Lung Cancer, and Bone Marrow Aspiration. Dr. Orsini is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nahum's expertise for a condition
ConditionClose
    View All 23 Distinguished Conditions
    View All 47 Advanced Conditions
    View All 156 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile